MUSTANG BIO, INC. Increase (Decrease) in Interest Payable, Net
MUSTANG BIO, INC. (MBIO) reported Increase (Decrease) in Interest Payable, Net of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-18.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2019-03-18
- MUSTANG BIO, INC. increase (decrease) in interest payable, net for the quarter ending 2018-12-31 was $0.00.
- MUSTANG BIO, INC. increase (decrease) in interest payable, net for the quarter ending 2018-09-30 was $0.00.
- MUSTANG BIO, INC. increase (decrease) in interest payable, net for the quarter ending 2018-06-30 was $0.00.
- MUSTANG BIO, INC. increase (decrease) in interest payable, net for the quarter ending 2018-03-31 was $0.00.
- MUSTANG BIO, INC. increase (decrease) in interest payable, net for fiscal 2018 was $0.00.
- MUSTANG BIO, INC. increase (decrease) in interest payable, net for fiscal 2017 was -$413.00K, a 268.57% decline from fiscal 2016.
- MUSTANG BIO, INC. increase (decrease) in interest payable, net for fiscal 2016 was $245.00K.
| Period end | Increase (Decrease) in Interest Payable, Net 3 month | Increase (Decrease) in Interest Payable, Net 6 month | Increase (Decrease) in Interest Payable, Net 7 month | Increase (Decrease) in Interest Payable, Net 9 month | Increase (Decrease) in Interest Payable, Net 10 month | Increase (Decrease) in Interest Payable, Net 12 month |
|---|---|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $0.00 derived: sum of 2 quarters · filed 2019-03-18 | $0.00 derived: sum of 3 quarters · filed 2019-03-18 | $0.00 10-K · filed 2019-03-18 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $0.00 derived: sum of 2 quarters · filed 2018-11-13 | $0.00 10-Q · filed 2018-11-13 | $0.00 derived: sum of 4 quarters · filed 2019-03-18 | ||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $0.00 10-Q · filed 2018-08-13 | $0.00 derived: sum of 3 quarters · filed 2019-03-18 | $0.00 derived: sum of 4 quarters · filed 2019-03-18 | ||
| 2018-03-31 | $0.00 10-Q · filed 2018-05-14 | $0.00 derived: sum of 2 quarters · filed 2019-03-18 | $0.00 derived: sum of 3 quarters · filed 2019-03-18 | -$2.00K derived: sum of 4 quarters · filed 2019-03-18 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $0.00 derived: sum of 2 quarters · filed 2019-03-18 | -$2.00K derived: sum of 3 quarters · filed 2019-03-18 | -$413.00K 10-K · filed 2019-03-18 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$2.00K derived: sum of 2 quarters · filed 2018-11-13 | -$413.00K 10-Q · filed 2018-11-13 | -$446.00K derived: sum of 4 quarters · filed 2018-11-13 | ||
| 2017-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | -$413.00K 10-Q · filed 2018-08-13 | -$446.00K derived: sum of 3 quarters · filed 2018-08-13 | -$342.00K derived: sum of 4 quarters · filed 2018-08-13 | ||
| 2017-03-31 | -$411.00K 10-Q · filed 2018-05-14 | -$444.00K derived: sum of 2 quarters · filed 2018-05-14 | -$340.00K derived: sum of 3 quarters · filed 2018-05-14 | -$247.00K derived: sum of 4 quarters · filed 2018-05-14 | ||
| 2016-12-31 | -$33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $71.00K derived: sum of 2 quarters · filed 2018-03-29 | $164.00K derived: sum of 3 quarters · filed 2018-03-29 | $245.00K 10-K · filed 2018-03-29 | ||
| 2016-09-30 | $104.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $197.00K derived: sum of 2 quarters · filed 2017-11-14 | $278.00K 10-Q · filed 2017-11-14 | |||
| 2016-06-30 | $93.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $174.00K 10-Q · filed 2017-08-14 | ||||
| 2016-03-31 | $81.00K 10-Q · filed 2017-05-15 | |||||
| 2015-12-31 | $168.00K 10-K · filed 2018-03-29 | |||||
| 2015-09-30 | $99.00K 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |